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الطيف السريري للشلل السفلي التشنجي الوراثي يف األطفال
دراسة 74 حالة
رو�شان كول، فتحية املر�شدي، في�شل العزري ، راجنيت ماين، رنا عبد الرحيم ، فيفيك كول، اآمنة الفطي�شية
الطريقة:  عمان.  �شلطنة  يف  االأطفال  يف  الوراثي  الت�شنجي  ال�شفلي  ال�شلل  ا�شتك�شاف  هو  الدرا�شة  هذه  من  الهدف  كان  الهدف:  امللخ�ص: 
اأجريت هذه الدرا�شة باأثر رجعي من الفرتة ما بني يناير 1994 و اأغ�شط�س 2011 على االأطفال الذين يعانون من تاأخر التطور النمائي، 
اًل، مبا يف  مف�شّ واالأ�رسة  الوالدة  تاريخ  ت�شجيل  الهرمي. مت  ال�شبيل  متناظرة  احلركة مع وجود عالمات  ومعوقات  امل�شية،  وا�شطرابات 
ذلك �شن ظهور االأعرا�س. و�شفت اإ�شابات االأطفال باأنها اإما نقية اأو معقدة من طيف ال�شلل ال�شفلي الت�شنجي الوراثي ا�شتنادا اإىل معايري 
خالل الدرا�شة، مت  النتائج:  اأي�شا فح�س االآباء وجميع االأ�شقاء.  اأكرث ، مت  اأو  الت�شخي�س املتبعة. يف االأ�رس التي لديها طفل م�شاب واحد 
%91 من احلاالت، 44 طفاًل  74 طفال من 31 عائلة لديها ال�شلل ال�شفلي الت�شنجي الوراثي. وجدت ن�شبة القرابة االأبوية يف  ت�شخي�س 
)%59.4( يعانون من ظهور املر�س يف اإطار عام واحد من العمر. كان معقد النوع االأكرث �شيوعا ووجد يف %81.1. وكان اكتناف  الكالم 
والتخلف العقلي، وال�رسع والت�شوهات املرتبطة االأكرث �شيوعا. لوحظت تغيريات غري حمددة للمادة البي�شاء وت�شوهات اجل�شم الثفني يف 
%24.3 من احلاالت يف الت�شوير بالرنني املغناطي�شي. اال�ستنتاج: و�شفت الدرا�شة املظاهر ال�رسيرية يف 74 طفال مع  ظهورال�شلل ال�شفلي 
الت�شنجي متنحي الوراثة  يف 81.1%.
مفتاح الكلمات: �شلل �شفلي ت�شنجي؛ �شلل �شفلي ت�شنجي وراثي؛ وراثي متنحي؛ االأطفال ذوي االحتياجات اخلا�شة؛ عمان.
abstract: Objectives: The aim of the study was to explore the spectrum of hereditary spastic paraplegia (HSP) 
in children in Oman. Methods: This retrospective study was carried out between January 1994 and August 2011 on 
children with delayed development, gait disorders and motor handicaps, with signs of symmetrical pyramidal tract 
involvement. A detailed perinatal and family history, including the age of onset of symptoms, was recorded. The 
children were labelled as having either the pure or complicated form of HSP based on the established diagnostic 
criteria. In families with more than one affected child, parents and all other siblings were also examined. Results: 
Within the study, 74 children from 31 families were diagnosed with HSP. Parental consanguinity was seen in 91% of 
cases, with 44 children (59.4%) experiencing onset of the disease under one year of age. Complicated HSP was the 
most common type, seen in 81.1%. Speech involvement, mental retardation, and epilepsy were the most common 
associated abnormalities. Nonspecific white matter changes and corpus callosum abnormalities were noted in 
24.3% of cases on magnetic resonance imaging. Conclusion: The study described clinical features of 74 children 
with HSP. Autosomal recessive complicated HSP was seen in 81.1% of cases. 
Keywords: Spastic Paraplegia, Hereditary; Spastic paraplegia, autosomal recessive; Disabled Children; Oman.
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Advances in Knowledge 
- This study examined the largest series of hereditary spastic paraplegia (HSP) in children in Oman.
- An autosomal recessive pattern of inheritance was seen in all cases in the study.
- Early onset of symptoms was seen in the majority of patients (~60%). 
-  Microcephaly was often seen in the children in this study.
- Magnetic resonance imaging showed white matter abnormalities in 24.3% of cases.
- A differential diagnosis of HSP should be considered if the history and clinical features do not suggest cerebral palsy.
Application to Patient Care
- Early diagnosis is essential in cases of HSP in children.
- Multidisciplinary care should be implemented as soon as the initial diagnosis is made in order to prevent handicaps.
- Support groups should be set up in Oman for children afflicted with HSP.
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Hereditary spastic paraplegia (HSP) is defined as a neurological disorder characterised by progressive symmetrical 
pyramidal tract dysfunction with onset in the lower 
limbs resulting in weakness, mainly of the lower 
extremities.1 The onset of the disease can be from 
early childhood up to 70 years of age.2 Childhood-
onset HSP needs to be differentiated from more 
common conditions like cerebral palsy and other 
mimicking neurodegenerative disorders that 
particularly affect the white matter of the brain.3 
HSP is classified as either pure or complicated 
based on well-established criteria.4,5 The disease 
is mainly reported in adults and there have been 
only a few studies in children.5,6 Autosomal 
dominant, X-linked and autosomal recessive 
modes of inheritance have been described.7 The 
autosomal dominant variety is the most common 
type, reported in 70–80% of all cases of HSP seen so 
far.5,8 Previous data from Oman were limited to two 
reports of two large families involving 16 children 
with novel genetic mutations.9,10 The present study 
describes clinical features of HSP in 74 children, 
including the previous study of 16 children in which 
a genetic work-up has already been done.  
Methods
This work was carried out from January 1994 
to August 2011 at the Sultan Qaboos University 
Hospital (SQUH), Muscat, Oman, which is one of 
Oman’s tertiary referral hospitals. Children with 
delayed development, gait disorders and motor 
handicaps, who had signs of symmetrical pyramidal 
tract involvement, were included. Children who 
had been diagnosed with cerebral palsy at another 
hospital or had been referred for neurological 
opinion were also included if the features were 
suggestive of HSP. 
A detailed history was taken for all cases 
regarding perinatal events, the age of onset of 
symptoms and the family history. All children were 
examined independently by two child neurologists 
and their HSP was classified as pure or complicated 
based on the established diagnostic criteria.4,5 In 
families with more than one affected child, the 
parents and all other siblings were examined for 
abnormal neurological signs. Affected cousins 
could not be examined as they refused to come for 
a check-up. 
An intelligence quotient (IQ) assessment 
was done only in one child as the majority of the 
children in the study (60%) were under one year 
of age. Cognitive impairment (mental retardation) 
was assessed based on the achievement of mental 
and social milestones and on a developmental 
assessment test administered at the time of clinical 
examination. Ophthalmological check-ups were 
performed in all cases. Besides baseline blood tests 
and tandem mass spectrometry, an assessment of 
lactate, ammonia and creatine kinase levels was also 
performed for all cases. When indicated, lysosomal 
enzymes, very long chain fatty acids, plasma amino 
acids, and urine organic acids were also estimated. 
Oman’s population has a large number of metabolic 
and neurodegenerative disorders; however, these 
were excluded on clinical features and appropriate 
laboratory investigations. Vitamin B12 levels were 
also tested if a deficiency was suspected. Magnetic 
resonance imaging (MRI) scans of the brain and 
spinal cord were done in all cases at the time of 
presentation and in 12 others on follow-up. 
The progression of the disease was based on 
the clinical criteria of worsening spasticity and 
gait, deterioration of muscle power and declining 
school performance. Nerve conduction studies, 
brainstem auditory evoked potentials (BAEPs) and 
visual evoked potentials (VEPs) were performed in 
all cases. An electroencephalograph was recorded if 
there had been a history of seizures. A genetic work-
up was done in the two large families who had been 
studied and reported earlier.9,10 A second study, to 
define the underlying genetic changes for the rest of 
the children, is planned in the near future.
The basis for the diagnosis of pure HSP was 
drawn from already-established criteria.1,4,5 First, 
children were considered developmentally delayed 
based on slow development or walking gait 
abnormalities with a static or slowly progressive 
course, and examination findings of symmetrical 
- Genetic diagnosis should be undertaken for the families, and an antenatal diagnosis made, in order to prevent further cases of HSP in 
future pregnancies. 
- Genetic counselling should be made available to affected families.
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pyramidal tract features (weakness, hypertonia, 
hyperreflexia, upgoing plantars, plantar flexion of 
the feet and contractures at a later stage) mainly 
affecting lower limbs, with normal or minimal 
involvement of the upper limbs. Second, a family 
history of a sibling or a cousin with a similar illness 
was an important indicator of the condition. Third, 
MRIs of the brain and spinal cord that were normal 
or had nonspecific white matter changes (white 
matter hyperintensities) in the brain at the time 
of initial presentation or on follow-up were also 
included if clinical features were suggestive of HSP. 
The basis for the diagnosis of complicated HSP 
was the presence of one or more features such as 
microcephaly, seizures, mental retardation, delayed 
language development, dysarthria, abnormal eye 
findings, progressive course and abnormal imaging, 
in addition to the features of pure HSP.
Exclusion criteria included: 1) children with 
static encephalopathies (cerebral palsy) related to 
perinatal complications; 2) those with diseases 
affecting the grey/white matter of the brain 
(gangliosidoses, leukodystrophies) and 3) the 
presence of basal ganglia disorders, hereditary 
neuropathies, vitamin B12 deficiencies, spinal cord 
trauma or demyelinating diseases. 
This study was approved by the ethical 
committee of the College of Medicine & Health 
Sciences at Sultan Qaboos University.
Results
In the course of our study, 74 children with HSP 
were seen (42 males [56.8%] and 32 [43.2%] females). 
At the time of initial diagnosis, 42 were labelled as 
complicated HSP; 18 others progressed on follow-
up and 14 were determined to have the pure form 
of HSP. The age of onset was under one year in 44 
(59.4%) children. The children diagnosed in the 
initial years are adults now and have experienced 
progression of the disease. In 30 families, there was 
more than one child affected. Only one family had a 
single case, which was presumed to be sporadic. On 
having more children, the chance of having another 
child affected with the disease is possible. The age 
of initial presentation ranged from 7 months to 15 
years, 5 months, with a mean of 5 years, 8 months. 
All children had normal perinatal histories. Parental 
consanguinity was seen in 91% of the children. 
There was an additional family history of affected 
cousins in 6 of the families. However, the cousins 
were not examined as they were reluctant to visit the 
hospital; hence, they were not included in the study. 
Cognitive impairment (mental retardation) was 
seen in 17 children (23%). Speech-related problems, 
mainly delayed language and dysarthria, were 
seen in 27 (36.5%). Ophthalmologic examinations 
showed retinal pigmentary changes in four cases, 
Table 1: Various clinical features in children with 
hereditary spastic paraplegia
Feature     n        %
Age of onset
     Birth 15 20.27
     Less than 6 months 12 16.21
     6 months–1 year 17 22.97
     1–4 years 12 16.21
     4–10 years 15 20.27
     10 years and above 3 4.05
Speech abnormalities
     Dysarthria 16 21.60
     Language delay 6 8.10
     Developmental aphasia 5 6.75
     Normal 47 63.50
Mental retardation 17 22.97
Epilepsy 13 17.56
Cerebellar features 9 12.16
Microcephaly 8 10.80
Extra pyramidal features 6 8.10
Simple febrile fit 1 1.35
Eye changes 6 8.10
     Pigmentary retinopathy 4 5.40
     Anterior dystrophy 1 1.35
     Optic disc pallor 1 1.35
Abnormal MrI findings 18 24.32
     Nonspecific white matter changes 12 16.21
     Corpus callosum thin/agenesis 10 13.50
     Cerebellar volume reduction 1 1.35
Neurophysiology 
     Nerve conduction abnormal 1 1.35
     BAEP abnormal (delayed/flat) 5/3 6.75/4.05
     VEP poor waveform 1 1.35
 
MRI = magnetic resonance imaging; BAEP = brainstem auditory 
evoked potential; VEP = visual evoked potential.
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anterior dystrophy in one, and optic disc pallor in 
one. The details of other features are given in Table 
1. 
Neurometabolic disorders were initially 
suspected in a few children, but the disorders 
were excluded by performing tandem mass 
spectrometry, or by estimating lysosomal enzymes, 
very long chain fatty acids or urine organic acids. 
The vitamin B12 levels assessed in 6 children were 
normal. One child with HSP, who was suspected 
of having myopathy, underwent a muscle biopsy 
outside the country; the results were normal. Brain 
abnormalities, detected upon MRI, were noted 
in 18 cases. These abnormalities were noted at 
the first presentation or later on follow-up. MRI 
changes that were not noted initially in 12 children 
eventually appeared in 3 on follow-up examinations 
performed after the children’s symptoms 
worsened clinically. Overall, twelve children had 
nonspecific white matter changes (white matter 
hyperintensities) [Figures 1B and 2B]. A total of 10 
children had corpus callosum changes ranging from 
thin to absent, in addition to white matter changes 
[Figures 1A and 2A]. Basal ganglia and spinal cord 
abnormalities were not seen in any children. Entire 
brain volume reduction was noted in one child and 
another had cerebellar atrophy. Nerve conduction 
studies were normal in all except one. This patient 
had features of hereditary demyelinating motor 
sensory neuropathy. Brainstem AEPs were delayed 
in 5 children, while two had no response. VEPs were 
normal in all except one, who had poor waveform.
There are approximately 45,000 live births per 
year in Oman. As 74 children were seen over 18 
years, this gave an approximate incidence of 1 in 
11,000 live births. The incidence could be higher 
than this as patients of other tertiary care hospitals 
were not included in this study.
All the children in this study were managed by 
supportive therapy, including muscle relaxants, 
physiotherapy and occupational therapy. Some 
children received botox and a few had corrective 
orthopaedic surgery. One child underwent selective 
dorsal rhizotomy in the USA.
Discussion
Reaching a diagnosis of HSP is relatively 
challenging in the first two years of a child’s life 
when all investigations are normal and there is no 
relevant perinatal history indicating brain insult 
suggestive of cerebral palsy. A slowly progressing 
gait disorder with dominant pyramidal signs 
in the lower limbs and none or few sensory 
symptoms favour a diagnosis of HSP.1,2,7 Various 
other neurodegenerative disorders affecting the 
neuroaxis at this age need to be differentiated if 
the typical clinical features of a particular disease 
are not present.6 A detailed algorithm for the 
diagnosis of HSP in children must be followed.6 
The differential diagnosis in paediatric-onset HSP 
is different from the adult-onset type, as many 
Figure 1 A&B: Magnetic resonance imaging scan of the brain of a 13-year-old girl. (A) Sagittal T1W view showing 
moderate hypoplasia of the corpus callosum (arrows). (B) Axial T2W view showing non-specific hyperintense signal 
abnormalities in the periventricular white matter (arrows).
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children are misdiagnosed with cerebral palsy.6,7 
HSP should be considered a diagnosis of exclusion 
in children.5 Important diagnostic alerts against 
it are bulbar signs, early amyotrophy, asymmetric 
pyramidal tract lesions, extra pyramidal signs and 
peripheral neuropathy.5 
The presence of more than one affected child in a 
family or affected cousins was very helpful in making 
the HSP diagnosis. Following strict diagnostic 
criteria, we were able to give a detailed description 
of HSP in the children in our study, most of whom 
are still being followed-up at SQUH to look for 
progression of the disease and manifestations of any 
other disorders developing over time. As Oman has 
a large number of metabolic and neurodegenerative 
disorders, doctors must watch for the presence 
or development of other neurological disorders; 
however, none of our children have yet developed 
features of other neurological disorders. 
HSP is mainly reported in adults; there have 
been only a few studies in children.5,6 The autosomal 
dominant variety is the most common type 
reported, constituting 70–80% of all cases.5,8 We did 
not encounter cases with an autosomal dominant 
or X-linked inheritance pattern. An examination of 
siblings and parents was important for excluding 
this pattern of inheritance. All children in this study 
had an autosomal recessive inheritance pattern. 
Consanguinity may be the main underlying factor as 
consanguineous marriages are common in Oman. 
Depending upon the disease entity, consanguinity 
has been reported in 56.3–87.50% of cases.11,12 
Two forms of HSP were described initially: pure 
and complicated.2 Mainly pyramidal features and 
mild sensory abnormalities were noted in the pure 
form. Other neurological and non-neurological 
features were seen in the complicated form. Recently, 
diagnostic criteria for pure and complicated HSP 
have been suggested.5 The differentiation between 
the pure and complicated forms was evident upon 
presentation in 42 cases, while 18 were seen to 
progress over time. By their second decade, many 
of the children in this study had developed speech 
impairments, dysarthria, a decline of intellect, 
cerebellar disorders and a loss of ambulatory 
function. These features suggested the complicated 
form of HSP. The majority (81.1%) of the children 
in our study had complicated HSP which also 
comprised 65% of cases in an earlier study.13 In 
another series of 72 children, autosomal recessive 
HSP was seen in 17%, and 25% of these cases had 
complicated HSP.6 This wide variability in the pure 
and complicated forms in our study may be related 
to the particular cohort of patients, the geographical 
location, patient genetics and the possibility of 
consanguinity in the population. Other than these 
factors, the accuracy of a diagnosis of pure HSP 
has been questioned in the past.14 Observations of 
the children in this study lend further evidence to 
the hypothesis that the pure form of HSP is rare 
in children, in contrast to adult-onset autosomal 
dominant HSP. Over time, most patients invariably 
Figure 2 A&B: Magnetic resonance imaging scan of the brain of a four-year-old boy. (A) Sagittal T1W view demonstrating 
marked hypoplasia of the corpus callosum (arrows). (B) Axial T2W view showing hyperintense signal abnormalities in 
the periventricular trigon white matter (arrows).
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fall into the group of complicated HSP.
A large number of the children in this study 
(59.45%) presented with symptoms at under one 
year of age, and the majority (56/74, 75.67%) 
presented at under 4 years. It was found that 20% 
had onset from birth, and 16% at around 6 months of 
age. This observation was based on the history taken 
from the parents. It was observed that the children 
with onset at under one year continued to achieve 
milestones, although with delays, up to the age of 
about 4 years and that subsequently progressive 
weakness started. This could be related to a growth 
spurt overtaking the disease process in this age 
group, as observed in many neurodegenerative 
diseases. This was not noted in the children with 
onset after 4 years of age. These children continued 
a downhill course after the onset of weakness.  
Speech involvement was noted in 27 children 
(36.5%), dysarthria being the most common 
(16, 21.6%), while 6 (8.1%) had delayed language 
development. Mental retardation was noted in 17 
(23%) cases of complicated HSP in the current study. 
Cognitive impairment over time has been reported 
in all types of HSP.5 Mental retardation in HSP has 
been reported in several previous studies.5,7,15–19 
Some of our patients experienced a worsening 
of cognitive functions with disease progression, 
as noted previously.19,20 However, in this cohort, 
this observation could not be substantiated by an 
appropriate IQ assessment.
Epilepsy is not a common feature of HSP; 
however, there are case reports and families with 
special genetic abnormalities associated with 
epilepsy.21 Epilepsy was noted in 13 (17.5%) of our 
patients; 3 of them had a thin corpus callosum.9,10 
Different types of seizures have been associated with 
HSP.5,21 In the current study, tonic-clonic seizures 
were found in 7 children, myoclonic in 4, and partial 
in two. Cerebellar features may be seen at the onset 
of the disease or later on after progression of the 
disease.5,9,10,17,20,22 In severe cases with spasticity and 
contractures, cerebellar features may be difficult 
to recognise. Cerebellar features were seen in 9 
children (12.1%), although MRI scanning showed 
cerebellar atrophy in only one.
Microcephaly is an uncommon feature in adult-
onset cases of HSP and has been reported only in 
a few studies.5,15,23 It was noted in 8 (10.8%) of our 
patients; this is suggestive of early onset illness 
affecting brain growth and development. Those 
with adult-onset HSP initially had normal brain 
growth and development—hence the normal head 
size. Extrapyramidal features, mainly in the form 
of dystonia, were noted in 6 (8.1%) of our patients 
although no imaging changes in the basal ganglia 
were seen, except generalised atrophy (decreased 
brain volume) in one child. This may be a part of the 
global atrophy of the brain noted in some of these 
patients.5
Eye abnormalities in the form of pigmentary 
retinopathy and disc pallor were noted in 6 (8.1%) 
patients. Eye abnormalities like macular changes, 
pigment migration, and atrophy have been reported 
previously in other studies.5,17,24,25
The majority of children with HSP have normal 
MRI results, as was seen in 75.6% of our patients. 
Abnormal MRI images were seen in 18 (24.3%) 
patients in the white matter, corpus callosum or 
both. Nonspecific white matter changes in the 
brain, namely leukoencephalopathy or white 
matter hyperintensities, were the most common 
findings in these children, and were noted in 12 
out of 18 (66.7%). These white matter changes have 
been reported before in the literature.9,10,17,20 Loss 
of volume (thinning) and agenesis of the corpus 
callosum were seen in 10 out of 18 (55.5%) patients. 
Involvement of the corpus callosum was the second 
most common abnormality found by MRI in our 
patients. There are several reports in the literature 
of white matter hyperintensities (diffuse or patchy) 
and corpus callosum abnormalities in association 
with HSP.9,10,17,19,20,26–30 
Thinning of the cervical and thoracic spinal cord 
has been noted in HSP.31 Volume loss is an expected 
finding as there is a degeneration of the longer 
corticospinal tracts to the spinal cord (mainly to the 
lower limbs) and dorsal column pathway within the 
spinal cord.5,32 However, this has not been noted in 
our patients to date. This study noted abnormalities 
at initial presentation or on follow-up in the brain 
MRIs only, but no changes were seen on follow-up 
in the spinal cord in the few children who underwent 
repeat MRIs. It may be possible to see these changes 
in the spinal cord at a later stage.
In most cases of pure HSP, nerve conduction 
studies are normal.2 Sensory impairment has 
been reported in 10–65% of cases of pure HSP; 
however, nerve conductions have been found to 
be normal.5,17,25,33 Sensory abnormalities on clinical 
examination in children are the most difficult ones 
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to detect. In this study, all children had normal 
nerve conduction velocities except in one whose 
abnormality was associated with hereditary motor 
sensory neuropathy. Abnormalities of the central 
motor conduction times have also been reported. 
Abnormalities of somatosensory evoked potentials 
in the form of low amplitudes also have been 
reported.34 Similarly, abnormal BAEPs and VEPs 
have been reported previously. These are rare 
manifestations in HSP.34–36 We found abnormal 
BAEPs in 5 patients (6.7%) and VEPs in one (1.3%). 
The most common genes associated with 
recessive HSP are SPG5A, SPG7, SPG11, and 
SPG15.2 The pure form with variable age of onset 
and slow progression is located in the SPG5A 
gene.22 In the two previous studies from Oman on 
16 children, 9 children with complicated HSP were 
genetically mapped to a new locus on 8p12-p11.21 
and 7 children with the SPG35 gene were mapped 
to 16q21-q23.1,9,10 In the rest of the children, genetic 
studies are expected to be undertaken in the future. 
Specific molecular genetic tests will help in easy 
and early diagnosis and help patients to avoid 
invasive and costly work-ups.2 In over 50% of cases 
of autosomal dominant HSP, a molecular diagnosis 
is possible.2 The loci of at least 44 spastic paraplegia 
genes have been mapped, and 20 genes have been 
identified to date.2,20 A systematic review of clinical 
features and genetic studies from 1985 to 2008 was 
reported in a recent study.2  
There are several hypotheses to explain the 
pathophysiologic mechanism of HSP. Malfunction 
of the axonal transport and membrane trafficking are 
emerging as likely mechanisms.2,37 Interference in 
the axonal transport of macromolecules, organelles 
and their cargoes to the longest neurons in the spinal 
cord result in HSP.37,38 Mitochondrial dysfunction 
could also affect the efficient transport of signals, 
molecules, and organelles to and from the nerve 
terminals.20 Mutation of fatty acid 2-hydroxylase 
(FA2H) was reported as the underlying mechanism 
of the complicated form of HSP in SPG35.20
Management of these HSP-affected children is 
a challenge. Multidisciplinary approaches involving 
several specialties can help them and their families. 
Locating the responsible genes and understanding 
the disease mechanism, and then translating these 
findings into therapies is a long term undertaking.38,39 
The goal for the future is to prevent such severe 
forms of autosomal recessive HSP. Genetic studies 
will help in the accurate diagnosis of patients, the 
detection of asymptomatic cases and prenatal 
diagnosis in families. This will eventually prevent 
the disease. 
Life expectancy in those with adult-onset HSP 
is mostly normal.5,7 This may not be true in children 
as we have seen children become wheelchair-bound 
by their teens. The oldest survivor in this study is 
a 23-year-old male who is bedridden and severely 
handicapped.
This study had the limitation that there was no 
supportive genetic study on 58 of the patients. It is 
possible that some rare neurometabolic disorder 
may be detected in some of them on long-term 
follow-up.
Conclusion
Autosomal recessive complicated HSP is the 
main form of HSP seen in children in the Arabian 
Peninsula, with an approximate incidence of 1 
in 11,000 live births. The majority of children 
experience onset at under 4 years of age. In the 
initial few years, they do not show deterioration 
in motor functions but then show progressive 
weakness. Speech involvement, mental retardation, 
epilepsy and microcephaly were commonly 
associated features in this study. Future genetic 
studies should reveal whether these children are 
experiencing a different genetic mutation from the 
previously identified genes involved in HSP or have 
totally novel mutations.
declaration
The authors declare no conflict of interest in this 
study, and that no financial help was received for 
the study from SQUH or any private party. 
References
1. Harding AE. Hereditary spastic paraplegia. Semin 
Neurol 1993; 13:333–6.
2. Salinas S, Proukakis C, Crosby A, Warner TT. 
Hereditary spastic paraplegia: Clinical features and 
pathogenetic mechanisms. Lancet Neurology 2008; 
7:1127–37.
3. Rainier S, Sher C, Reish O, Thomas D, Fink JK. De 
novo occurrence of novel SPG 3A/atlastin mutation 
presenting as cerebral palsy. Arch Neurol 2006; 
63:445–7.
4. Harding AE. Classification of hereditary ataxias and 
Clinical Spectrum of Hereditary Spastic Paraplegia in Children 
A study of 74 cases
378 | SQU Medical Journal, August 2013, Volume 13, Issue 3
paraplegias. Lancet 1983; 1:1151–5.
5. McDermott CJ, White K, Bushby K, Shaw PJ. 
Hereditary spastic paraparesis: A review of new 
developments. J Neurol Neurosurg Psychiatry 2000; 
69:150–60.
6. deBot ST, Van de Warrenburg BPC, Kremer HPH, 
Willemsen MAAP. Child neurology: Hereditary 
spastic paraplegia in children. Neurology 2010; 
75:e75–9.
7. McDermott CJ, Shaw PJ. Hereditary spastic 
paraparesis. In: AA Eisen, PJ Shaw, Eds. Handbook of 
Clinical Neurology Series, Motor Neuron Disorders 
and Related Diseases. 3rd ed. Amsterdam: Elsevier, 
2007. Pp. 327–52. 
8. Depienne C, Stevanin G, Brice A, Durr A. Hereditary 
spastic paraplegias: An update. Curr Opin Neurol 
2007; 20:674–80.
9. Al-Yahyaee S, Al-Gazali LI, De Jonghe P, AlBarwany 
H, Al-Kindi M, DeYriedt E, et al. A novel locus 
for hereditary spastic paraplegia with thin corpus 
callosum and epilepsy. Neurology 2006; 66:1230–4.
10. Dick KJ, Al-Mjeni R, Bashir W, Koul R, Simpson MA, 
Patton MA, et al. A novel locus for an autosomal 
recessive hereditary spastic paraplegia (SPG35) 
maps to 16q21-q23. Neurology 2008; 71:248–52.
11. Rajab A, Patton MA. A study of consanguinity in the 
Sultanate of Oman. Ann Hum Biol 2000; 27:321–6.
12. Al-Maawali AA, Joshi SN, Koul RL, Al-Maawali 
AA, Al-Sedari HS, Al-Amri BM, et al. Spectrum 
of paediatric lysosomal storage disorders in Oman. 
Sultan Qaboos Univ Med J; 2012: 12:295–9.
13. Appleton RE, Farrel K, Dunn HG. ‘Pure’ and 
‘complicated’ forms of HSP presenting in childhood. 
Dev Med Child Neurol 1991; 33:304–12.
14. Figlewicz DA, Bird TD. ‘Pure’ hereditary spastic 
paraplegias. The story becomes complicated. 
Neurology 1999; 53:5–7.
15. Farah S, Sabry MA, Al-Shubaili AF, Anim JT, 
Hussain JM, Montaser MA, et al. Hereditary spastic 
paraparesis with distal muscle wasting, microcephaly, 
mental retardation, arachnodactyly, and tremors: 
New entity? Clin Neurol Neurosurg 1997; 99:66–70. 
16. Wilkinson PA, Crosby AH, Turner C, Bradley LJ, 
Ginsberge L, Wood NW, et al. A clinical genetic and 
biochemical study of SPG7 mutations in hereditary 
spastic paraplegia. Brain 2004; 127:973–80.
17. Stevanin G, Santorelli FM, Azzedine H, Countinho 
P, Chomilier J, Denova PS, et al. Mutations in SPG 
11 encoding spastascin are a major cause of spastic 
paraplegia with thin corpus callosum. Nat Genet 
2007; 39:366–72.
18. Dursun U, Koroglu C, Kocasoy Orhan E, Ugur SA, 
Tolun A. Autosomal recessive  spastic paraplegia 
(SPG45) with mental retardation maps to 
10q24.3-q25.1 Neurogenetics 2009; 10:325–31.
19. Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir 
M, Lossos A, et al. Mutations in SPG11 are frequent 
in autosomal recessive spastic paraplegia with this 
corpus callosum, cognitive decline and lower motor 
neuron degeneration. Brain 2008; 131:772–84.
20. Dick KJ, Eckhardt M, Paisán-Ruiz C, Alshehhi A, 
Proukakis C, Sibtain NA, et al. Mutation of FA2H 
underlies a complicated form of hereditary spastic 
paraplegia (SPG35). Hum Mutat 2010; 4:E1251–60.
21. Webb S, Flanagan N, Callaghan N, Hutchinson M. 
A family with hereditary spastic paraparesis and 
epilepsy. Epilepsia 1977; 38:495–9.
22. Hentati A, Pericak-Vance MA, Hung WY, Belal 
S, Laing N, Boustany RM, et al. Linkage of 
pure autosomal recessive spastic paraplegia to 
chromosome 8 markers and evidence of genetic 
locus heterogeneity. Hum Mol Genet 1994; 3:1263–
7.
23. Teebi AS, Miller S, Ostrer H, Eydoux P, Colomb-
Brockmann C, Oudjhane K, et al. Spastic paraplegia, 
optic atrophy, microcephaly with normal intelligence 
and XY sex reversal: A new autosomal recessive 
syndrome? J Med Genet 1998; 35:759–62.
24. Leys A, Gilbert HD, Van De Sompel W, 
Verougstraete C, Devriendt K, Lagae L, et al. 
Familial spastic paraplegia and maculopathy with 
juxtrafoveolar retinal telengiectasias and subretinal 
neovascularisation. Retina 2000; 20:184–9.
25. Hanein S, Martin E, Boukhris A, Byrne P, Goizet 
C, Hamri A, et al. Identification of the SPG15 
gene, encoding spastizin, as a frequent cause of 
complicated autosomal recessive spastic paraplegia, 
including Kjellin syndrome. Am J Hum Genet 2008; 
82:992–1002.
26. Shibasaki Y, Tanaka H, Iwabuchi K, Kawasaki S, 
Kondo H, Uekawa K et al. Linkage of autosomal 
recessive hereditary spastic paraplegia with 
mental impairment and thin corpus callosum to 
chromosome 15A13-15. Ann Neurol 2000; 48:108–
12.
27. Casali C, Valente EM, Bertini E, Montagna G, 
Criscuolo C, Di Michele G, et al. Clinical and genetic 
studies in hereditary spastic paraplegia with thin 
corpus callosum. Neurology 2004; 27:262–8.
28. Orlacchio A, Kawarai T, Totaro A, Errico A, St 
George-Hyslop PH, Rugarli EI, et al. Hereditary 
spastic paraplegia: Clinical genetic study of 15 
families. Arch Neurol 2004; 61:849–55.
29. Winner B, Uyanik G, Gross C, Lange M, Schulte-
Mattler W, Schuierer G, et al. Clinical progression 
and genetic analysis in hereditary spastic paraplegia 
with thin corpus callosum in spastic gait gene 11 
(SPG11). Arch Neurol 2004; 61:117–21.
30. Goizet C, Boukhris A, Durr A, Beetz C, Truchetto 
J, Tesson C, et al. CYP7B1 mutations in pure and 
complex forms of hereditary spastic paraplegia type 
5. Brain 2009; 132:1589–1600.
31. Hedera P, Eldevik OP, Maly P, Rainier S, Fink JK. 
Roshan Koul, Fathiya M. Al-Murshedi, Faisal M. Al-Azri, Ranjit Mani, Rana A. Abdelrahim, Vivek Koul and Amna M. Alfutaisi
Clinical and Basic Research | 379
Spinal cord MRI in autosomal dominant hereditary 
spastic paraplegia. Neuroradiology 2005; 47:730–4. 
32. Bruyn RPM. The neuropathology of hereditary 
spastic paraplegia. Clin Neurol Neurosurg 1992; 
94:S16–18.
33. Schady W, Smith CML. Sensory neuropathy in 
hereditary spastic paraplegia. J Neurol Neurosurg 
Psychiatry 1994; 57:693–8.
34. Sartucci F, Tavani S, Murri L, Saggliocco L. Motor 
and somatosensory evoked potentials in autosomal 
dominant hereditary spastic paraplegia linked to 
chromosome 2pSPG4. Brain Res Bull 2007; 74:243–
9.
35. Rossini PM, Cracco JB. Somatosensory and brainstem 
auditory evoked potentials in neurodegenerative 
system disorders. Eur Neurol 1987; 26:176–88.
36. Happel LT, Rothschild H, Garcia C. Visual evoked 
potentials in two forms of hereditary spastic 
paraplegia. Electroencephalogr Clin Neurophysiol 
1980; 48:233–6.
37. Crosby AH, Proukakis C. Is the transportation 
highway the right road for hereditary spastic 
paraplegias? Am J Hum Genet 2000; 71:1009–16.
38. Tarrade A, Fassier C, Courageot S, Charvin D, Vitte 
J, Peris L, et al. A mutation of spastin is responsible 
for swelling and impairment of transport in a region 
of axon characterized by changes in microtubule 
composition. Hum Mol Genet 2006; 15:3544–58.
39. Alexandra D. Genetic testing for spastic paraplegia. 
Neurology 2008; 71:236–8.
